4//SEC Filing
Martell Christopher 4
Accession 0000950170-25-090196
CIK 0001841387other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:30 AM ET
Size
7.0 KB
Accession
0000950170-25-090196
Insider Transaction Report
Form 4
Martell Christopher
Director
Transactions
- Award
Common Stock
2025-06-25$4.67/sh+111,349$520,000→ 111,349 total(indirect: By Spouse)
Holdings
- 152,000(indirect: By LLC)
Common Stock
- 283,514(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.
- [F2]Shares held by Spouse.
- [F3]Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
- [F4]Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873465
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 8:30 AM ET
- Size
- 7.0 KB